Clinical Trial Update: Sorafenib and Radioembolization With Sir-Spheres® for the Treatment of Metastatic Ocular Melanoma [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating the combination of sorafenib with Sir-Spheres Y-90 radioembolization for metastatic ocular melanoma; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Melanoma

Drugs mentioned

• Nexavar (Sorafenib)
• SIR-Spheres (yttrium-90 glass microspheres)

Snippet

Sponsor: Centre Hospitalier Universitaire Vaudois | Conditions: Ocular Melanoma | Phase 1 | Status: COMPLETED